35 kDa Hyaluronan Fragment (HA35) Reduces Chronic Inflammation of Skin

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 15, 2024

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions
Skin InflammationCosmetic Skin
Interventions
DRUG

35 kDa hyaluronan fragment HA35 injection

First, apply an appropriate amount of compound lidocaine cream to the treatment site ( national drug approval number H20063466 ; Beijing Ziguang Pharmaceutical Co., Ltd. ) waited for 60 minutes after applying hemp, and then injected the syringe containing sterile HA35 prepared in advance into the subcutaneous 1.0-1.5mm through the DermaShine PRO negative pressure microneedle importer ( Demasha, South Korea ).

Trial Locations (1)

Unknown

RECRUITING

Nahia Impex LLC, Ulaanbaatar

All Listed Sponsors
lead

Nakhia Impex LLC

INDUSTRY